Invention Grant
- Patent Title: Monoclonal antibodies directed against a novel pathogenic west African human immunodeficiency virus type 2 (HIV-2) group F isolate
-
Application No.: US14263517Application Date: 2014-04-28
-
Publication No.: US09650435B2Publication Date: 2017-05-16
- Inventor: Stephen M. Smith , Preston A. Marx, Jr.
- Applicant: Tulane University Health and Sciences Center
- Applicant Address: US LA New Orleans
- Assignee: The Administrators of the Tulane Educational Fund
- Current Assignee: The Administrators of the Tulane Educational Fund
- Current Assignee Address: US LA New Orleans
- Agency: McNeill Baur PLLC
- Main IPC: C07K16/10
- IPC: C07K16/10 ; C12N7/00 ; C12Q1/70 ; G01N33/569
Abstract:
Isolated monoclonal antibodies that bind to HIV-2 isolate NWK08F are provided. In some embodiments, the antibodies bind a polypeptide comprising the HIV-2NWK08F Env, Pol, or Nef proteins, or fragments thereof, respectively. Antigen-binding fragments and humanized versions of the antibody are also provided.
Public/Granted literature
- US20140234332A1 NOVEL HIV-2 ISOLATE Public/Granted day:2014-08-21
Information query
